Suppr超能文献

揭示干细胞、纳米技术和生物材料新兴领域中组织工程的多样化。

Uncovering the Diversification of Tissue Engineering on the Emergent Areas of Stem Cells, Nanotechnology and Biomaterials.

机构信息

Department of Pharmacy, Birla Institute of Technology and Science, Pilani (BITS-PILANI), Pilani Campus, Rajasthan 333031, India.

Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research (NIPER GUWAHATI), Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Govt. of India, NH 37, NITS Mirza, Kamrup-781125, Guwahati (Assam), India.

出版信息

Curr Stem Cell Res Ther. 2020;15(3):187-201. doi: 10.2174/1574888X15666200103124821.

Abstract

Damaged or disabled tissue is life-threatening due to the lack of proper treatment. Many conventional transplantation methods like autograft, iso-graft and allograft are in existence for ages, but they are not sufficient to treat all types of tissue or organ damages. Stem cells, with their unique capabilities like self-renewal and differentiate into various cell types, can be a potential strategy for tissue regeneration. However, the challenges like reproducibility, uncontrolled propagation and differentiation, isolation of specific kinds of cell and tumorigenic nature made these stem cells away from clinical application. Today, various types of stem cells like embryonic, fetal or gestational tissue, mesenchymal and induced-pluripotent stem cells are under investigation for their clinical application. Tissue engineering helps in configuring the stem cells to develop into a desired viable tissue, to use them clinically as a substitute for the conventional method. The use of stem cell-derived Extracellular Vesicles (EVs) is being studied to replace the stem cells, which decreases the immunological complications associated with the direct administration of stem cells. Tissue engineering also investigates various biomaterials to use clinically, either to replace the bones or as a scaffold to support the growth of stemcells/ tissue. Depending upon the need, there are various biomaterials like bio-ceramics, natural and synthetic biodegradable polymers to support replacement or regeneration of tissue. Like the other fields of science, tissue engineering is also incorporating the nanotechnology to develop nano-scaffolds to provide and support the growth of stem cells with an environment mimicking the Extracellular matrix (ECM) of the desired tissue. Tissue engineering is also used in the modulation of the immune system by using patient-specific Mesenchymal Stem Cells (MSCs) and by modifying the physical features of scaffolds that may provoke the immune system. This review describes the use of various stem cells, biomaterials and the impact of nanotechnology in regenerative medicine.

摘要

由于缺乏适当的治疗,受损或功能丧失的组织会危及生命。许多传统的移植方法,如自体移植物、同种移植物和同种异体移植物,已经存在了很长时间,但它们不足以治疗所有类型的组织或器官损伤。干细胞具有自我更新和分化为各种细胞类型的独特能力,可以成为组织再生的潜在策略。然而,它们也面临着一些挑战,如可重复性、不可控的增殖和分化、特定类型细胞的分离以及致瘤性,这些问题使这些干细胞远离了临床应用。如今,各种类型的干细胞,如胚胎、胎儿或妊娠组织、间充质和诱导多能干细胞,都在被研究用于临床应用。组织工程有助于将干细胞配置为发育成所需的有活力的组织,以便在临床上替代传统方法使用它们。使用干细胞衍生的细胞外囊泡(EVs)来替代干细胞的研究正在进行中,这可以减少与直接给予干细胞相关的免疫并发症。组织工程还研究了各种生物材料用于临床,要么替代骨骼,要么作为支架来支持干细胞/组织的生长。根据需要,有各种生物材料,如生物陶瓷、天然和合成可生物降解聚合物,以支持组织的替代或再生。与科学的其他领域一样,组织工程也正在整合纳米技术来开发纳米支架,为干细胞的生长提供和支持,模拟所需组织的细胞外基质(ECM)环境。组织工程还通过使用患者特异性间充质干细胞(MSCs)和改变支架的物理特性来调节免疫系统,这些特性可能会引发免疫系统的反应。本综述描述了各种干细胞、生物材料和纳米技术在再生医学中的应用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验